Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Almi Invest GreenTech is a Swedish early-stage venture capital investor focused on climate and environmental technology rather than a therapeutics developer. It operates within the Almi group and invests in Swedish startups with the potential to deliver significant climate or environmental benefit, including businesses in energy transition, circular materials, mobility, industrial decarbonization, and sustainable food systems. The organization has launched dedicated climate-focused funds, including a newer fund called Klimatfonden, and invests mainly at seed and Series A stages. As a result, Almi Invest GreenTech does not have a drug pipeline, therapeutic programs, or clinical-stage assets. For biotech analysts, the key point is that this is an investor that may back enabling or sustainability-related companies, including occasional life-science-adjacent industrial biotech businesses, but it is not itself a biotech or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Almi Invest GreenTech.